Statement of Retraction. EGFR Tyrosine Kinase Inhibitor (PD153035) Improves Glucose Tolerance and Insulin Action in High-Fat Diet–Fed Mice. Diabetes 2009;58:2910–2919. DOI: 10.2337/db08-0506. PMID: 19696185

Spremljeno u:
Bibliografski detalji
Izdano u:Diabetes
Glavni autori: Prada, Patricia O., Ropelle, Eduardo R., Mourão, Rosa H., de Souza, Claudio T., Pauli, Jose R., Cintra, Dennys E., Schenka, André, Rocco, Silvana A., Rittner, Roberto, Franchini, Kleber G., Vassallo, José, Velloso, Lício A., Carvalheira, José B., Saad, Mario J.A.
Format: Artigo
Jezik:Inglês
Izdano: American Diabetes Association 2017
Teme:
Statement of Retraction
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5482084/
https://ncbi.nlm.nih.gov/pubmed/28450418
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2337/db17-rt07a
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items